To evaluate potential role of HSP90 in the pathogenesis of lipid metabolic disorders, we measured the hepatic HSP90α and HSP90β levels in human specimens from 20 subjects with NAFLD (Table S1). This evidence concerns the gene HSP90AB1 and metabolic dysfunction-associated steatotic liver disease.